ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00949182
Recruitment Status : Completed
First Posted : July 30, 2009
Last Update Posted : January 14, 2014
Sponsor:
Information provided by (Responsible Party):
Andrew de la Torre, Rutgers, The State University of New Jersey

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : June 2013